Rituximab-associated agranulocytosis in children with refractory idiopathic nephrotic syndrome: case series and review of literature

摘要

Background. Agranulocytosis has been reported as a delayed-onset complication of rituximab treatment. However, the exact incidence and risk factors of this complication in patients with nephrotic syndrome remain unknown.